WHO: Michael Platt Penn Integrates Knowledge Professor James S. Riepe University Professor of Neuroscience Perelman School of Medicine

Gina Bryan, Michele W. Berger ・January 11, 2016

The University of Pennsylvania President’s Engagement Prize gave Penn graduate Shadrack Frimpong the opportunity to fulfill a dream he had been imagining for years: opening a clinic and school for girls in hi

Katherine Unger Baillie ・January 7, 2016

In Florida carpenter ant colonies, distinct worker castes called minors and majors exhibit pronounced differences in social behavior throughout their lives. In a new study published today in Science, a multi-institution team anchored at University of Pennsylvania found that these caste-specific behaviors are not set in stone.

Karen Kreeger ・December 31, 2015

Murray Grossman, MD, EdD, a professor of Neurology in the Perelman School of Medicine at the University of Pennsylvania and director of Penn’s Frontotemporal Degeneration (FTD) Center, recently received the Legal Clinic for

Lee-Ann Donegan ・December 31, 2015

Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature review and additional original research conducted by experts at the

Steve Graff ・December 30, 2015

Penn Medicine’s Gary Lichtenstein, MD, a professor of Medicine and Gary Wu, MD, the Ferdinand G.

Paul Foster ・December 30, 2015

Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer-induced weakness in the patient’s immune system – a weakness that in principle could be corrected with a HER2-targeted vaccine – according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Results of the study show that T cells from patien

Katie Delach ・December 30, 2015

Anil K. Rustgi, MD, chief of Gastroenterology in the Perelman School of Medicine at the University of Pennsylvania, is once again the recipient of a prestigious Research Professor Award from the American Cancer Society (ACS).

Lee-Ann Donegan ・December 28, 2015

For the third of all epilepsy patients who don’t respond to medication, an alternative is to locate the small cluster of neurons that act as the seed of a seizure’s aberrant electrical activity and surgically remove it. Unfortunately, such surgeries often fail to bring any relief.

Evan Lerner, Lee-Ann Donegan ・December 17, 2015